SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : VOLTAIRE'S PORCH-MODERATED -- Ignore unavailable to you. Want to Upgrade?


To: Dealer who wrote (45512)12/21/2001 10:09:15 AM
From: stockman_scott  Respond to of 65232
 
09:31 ET XOMA Limited (XOMA) 8.46 +0.30 (+3.7%): JP Morgan initiates coverage with a BUY rating and 12-month price target of $17; believes XOMA's biz model delivers a "pure play" on Xanelim's forecast commercial success while substantially mitigating the financial risks of drug development; firm projects over $1 bln in potential peak annual sales for the psoriasis treatment Xanelim